Related references
Note: Only part of the references are listed.Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma - Is cure possible?
Thomas Schnelldorfer et al.
ANNALS OF SURGERY (2008)
Most pancreatic cancer resections are R1 resections
Irene Esposito et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor
Arne Westgaard et al.
BMC CANCER (2008)
Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma
Arne Westgaard et al.
BMC CANCER (2008)
Pilot study of mutant ras peptide-based vaccine as an adjuvant treatment in pancreatic and colorectal cancers
Antoun Toubaji et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Kras mutation analysis of fine needle aspirate under EUS guidance facilitates risk stratification of patients with pancreatic mass
Fauze Maluf-Filho et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2007)
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer - A Randomized controlled trial
Helmut Oettle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Adjuvant therapy in pancreatic cancer - A critical appraisal
Helmut Oettle et al.
DRUGS (2007)
Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer
Nabeel Bardeesy et al.
GENES & DEVELOPMENT (2006)
Resected periampullary adenocarcinoma: 5-year survivors and their 6-to 10-year follow-up
Taylor S. Riall et al.
SURGERY (2006)
Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins
J. Kim et al.
GUT (2006)
Redefining the R1 resection in pancreatic cancer
C. S. Verbeke et al.
BRITISH JOURNAL OF SURGERY (2006)
Immunization with mutant p53- and K-ras-derived peptides in cancer patients:: Immune response and clinical outcome
DP Carbone et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Does anyone survive pancreatic ductal adenocarcinoma?: A nationwide study re-evaluating the data of the Finnish Cancer Registry
M Carpelan-Holmström et al.
GUT (2005)
Pancreatic Intraepithelial neoplasia
K Takaori et al.
PANCREAS (2004)
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer
JP Neoptolemos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
HLA-A3 restricted mutant ras specific cytotoxic T-lymphocytes induced by vaccination with T-helper epitopes
MK Gjertsen et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2003)
Intradermal ras peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant:: Clinical and immunological responses in patients with pancreatic adenocarcinoma
MK Gjertsen et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Share Paper
